The
need for biologic-based therapeutics that can be administered via the
subcutaneous roue and emergence of supporting devices
Subcutaneous
Biologics, Technologies and Drug Delivery Systems Market: Over the years, the incidence and prevalence of chronic
diseases, such as diabetes, multiple sclerosis and rheumatoid arthritis, have
increased significantly. Presently, the recommended treatment options for such
clinical conditions are mostly biologics, which need to be administered via
parenteral routes in order to ensure maxi...
more